MedPath

RIFATER COMPRIMIDOS RECUBIERTOS

RIFATER COMPRIMIDOS RECUBIERTOS

Commercialized
Register Number

58299

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Mar 31, 1989

Dosage Form

COMPRIMIDO RECUBIERTO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number58299
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (3)

ISONIAZIDAActive
Quantity: 50 mg
Name: ISONIAZIDA
PIRAZINAMIDAActive
Quantity: 300 mg
Name: PIRAZINAMIDA
RIFAMPICINAActive
Quantity: 120 mg
Name: RIFAMPICINA

ATC CLASSIFICATION (3)

J04A
J04AM
J04AM05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.